Vascular tumours in infants. Part I: benign vascular tumours other than infantile haemangioma
Corresponding Author
P.H. Hoeger
Department of Paediatric Dermatology, Catholic Children's Hospital Wilhelmstift, Hamburg, Germany
Correspondence
Peter Hoeger.
E-mail: [email protected]
Search for more papers by this authorI. Colmenero
Histopathology Department, Birmingham Children's Hospital, Birmingham, U.K
Search for more papers by this authorCorresponding Author
P.H. Hoeger
Department of Paediatric Dermatology, Catholic Children's Hospital Wilhelmstift, Hamburg, Germany
Correspondence
Peter Hoeger.
E-mail: [email protected]
Search for more papers by this authorI. Colmenero
Histopathology Department, Birmingham Children's Hospital, Birmingham, U.K
Search for more papers by this authorSummary
Vascular anomalies can be subdivided into vascular tumours and vascular malformations (VMs). While most VMs are present at birth and do not exhibit significant postnatal growth, vascular tumours are characterized by their dynamics of growth and (sometimes) spontaneous regression. This review focuses on benign vascular tumours other than infantile haemangiomas (IHs), namely pyogenic granuloma, eruptive pseudoangiomatosis, glomangioma, rapidly involuting and noninvoluting congenital haemangioma, verrucous haemangioma and spindle cell haemangioma. While some of them bear clinical resemblance to IH, they can be separated by age of appearance, growth characteristics and/or negative staining for glucose transporter 1. Separation of these tumours from IH is necessary because their outcome and therapeutic options are different. Semimalignant and malignant vascular tumours will be addressed in a separate review.
References
- 1Al Dhaybi R, Powell J, McCuaig C, Kokta V. Differentiation of vascular tumors from vascular malformations by expression of Wilms tumor 1 gene: evaluation of 126 cases. J Am Acad Dermatol 2010; 63: 1052–7.
- 2Trindade F, Tellechea O, Torrelo A et al. Wilms tumor 1 expression in vascular neoplasms and vascular malformations. Am J Dermatopathol 2011; 33: 569–72.
- 3North PE, Waner M, Mizeracki A, Mihm MC. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000; 31: 11–22.
- 4Pagliai KA, Cohen BA. Pyogenic granuloma in children. Pediatr Dermatol 2004; 21: 10–13.
- 5Browning JC, Eldin KW, Kozakewich HPW et al. Congenital disseminated pyogenic granuloma. Pediatr Dermatol 2009; 26: 323–7.
- 6Gordón-Núñez MA, De Vasconcelos Carvalho M, Benevenuto TG et al. Oral pyogenic granuloma: a retrospective analysis of 293 cases in a Brazilian population. J Oral Maxillofac Surg 2010; 68: 2185–8.
- 7Shields JA, Mashayekhi A, Kligman BE et al. Vascular tumors of the conjunctiva in 140 cases. Ophthalmology 2011; 118: 1747–53.
- 8Baselga E, Wassef M, Lopez S et al. Agminated, eruptive pyogenic granuloma-like lesions developing over congenital vascular stains. Pediatr Dermatol 2012; 29: 186–90.
- 9Hölbe HC, Frosch PJ, Herbst RA. Surgical pearl: ligation of the base of pyogenic granuloma – an atraumatic, simple, and cost-effective procedure. J Am Acad Dermatol 2003; 49: 509–10.
- 10Ghodsi SZ, Raziei M, Taheri A et al. Comparison of cryotherapy and curettage for the treatment of pyogenic granuloma: a randomized trial. Br J Dermatol 2006; 154: 671–5.
- 11Sud AR, Tan ST. Pyogenic granuloma-treatment by shave-excision and/or pulsed-dye laser. J Plast Reconstr Aesthet Surg 2010; 63: 1364–8.
- 12Tritton SM, Smith S, Wong L-C et al. Pyogenic granuloma in ten children treated with topical imiquimod. Pediatr Dermatol 2009; 26: 269–72.
- 13Cherry JD, Bobinski JE, Horvath FL, Comerci GD. Acute hemangioma-like lesions associated with ECHO viral infections. Pediatrics 1969; 44: 498–502.
- 14Prose NS, Tope W, Miller SE, Kamino H. Eruptive pseudoangiomatosis: a unique childhood exanthem? J Am Acad Dermatol 1993; 29: 857–9.
- 15Larralde M, Ballona R, Correa N et al. Eruptive pseudoangiomatosis. Pediatr Dermatol 2002; 19: 76–7.
- 16Yang JH, Kim JW, Park HS et al. Eruptive pseudoangiomatosis. J Dermatol 2006; 33: 873–6.
- 17Glick SA, Markstein EA, Herreid P. Congenital glomangioma: case report and review of the world literature. Pediatr Dermatol 1995; 12: 242–4.
- 18Mallory SB, Enjolras O, Boon LM et al. Congenital plaque-type glomuvenous malformations presenting in childhood. Arch Dermatol 2006; 142: 892–6.
- 19Goujon E, Cordoro KM, Barat M et al. Congenital plaque-type glomuvenous malformations associated with fetal pleural effusion and ascites. Pediatr Dermatol 2011; 28: 528–31.
- 20Brouillard P, Boon LM, Mulliken JB et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (‘glomangiomas’). Am J Hum Genet 2002; 70: 866–74.
- 21Hughes R, Lacour J-P, Chiaverini C et al. Nd:YAG laser treatment for multiple cutaneous glomangiomas: report of 3 cases. Arch Dermatol 2011; 147: 255–6.
- 22Fadell MF, Jones BV, Adams DM. Prenatal diagnosis and postnatal follow-up of rapidly involuting congenital hemangioma (RICH). Pediatr Radiol 2011; 41: 1057–60.
- 23Berenguer B, Mulliken JB, Enjolras O et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol 2003; 6: 495–510.
- 24Picard A, Boscolo E, Khan ZA et al. IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma. Pediatr Res 2008; 63: 263–7.
- 25Baselga E, Cordisco MR, Garzon M et al. Rapidly involuting congenital haemangioma associated with transient thrombocytopenia and coagulopathy: a case series. Br J Dermatol 2008; 158: 1363–70.
- 26Cole P, Kaufman Y, Metry D, Hollier L. Non-involuting congenital haemangioma associated with high-output cardiomyopathy. J Plast Reconstr Aesthet Surg 2009; 62: e379–82.
- 27Gorincour G, Kokta V, Rypens F et al. Imaging characteristics of two subtypes of congenital hemangiomas: rapidly involuting congenital hemangiomas and non-involuting congenital hemangiomas. Pediatr Radiol 2005; 35: 1178–85.
- 28Enjolras O, Mulliken JB, Boon LM et al. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001; 107: 1647–54.
- 29Trindade F, Torrelo A, Requena L et al. An immunohistochemical study of verrucous hemangiomas. J Cutan Pathol 2013; 40: 472–6.
- 30Imperial R, Helwig EB. Verrucous hemangioma. A clinicopathologic study of 21 cases. Arch Dermatol 1967; 96: 247–53.
- 31Jain VK, Aggarwal K, Jain S. Linear verrucous hemangioma on the leg. Indian J Dermatol Venereol Leprol 2008; 74: 656–8.
- 32Kaliyadan F, Dharmaratnam AD, Jayasree MG, Sreekanth G. Linear verrucous hemangioma. Dermatol Online J 2009; 15: 15.
- 33Calduch L, Ortega C, Navarro V et al. Verrucous hemangioma: report of two cases and review of the literature. Pediatr Dermatol 2000; 17: 213–17.
- 34Rupani AB, Madiwale CV, Vaideeswar P. Images in pathology: verrucous haemangioma. J Postgrad Med 2000; 46: 132–3.
- 35Wang G, Li C, Gao T. Verrucous hemangioma. Int J Dermatol 2004; 43: 745–6.
- 36Mankani MH, Dufresne CR. Verrucous malformations: their presentation and management. Ann Plast Surg 2000; 45: 31–6.
- 37Tennant LB, Mulliken JB, Perez-Atayde AR, Kozakewich HPW. Verrucous hemangioma revisited. Pediatr Dermatol 2006; 23: 208–15.
- 38Bodemer C, Fraitag S, Amoric JC et al. Spindle-cell hemangioendothelioma with monomelic and multifocal form in a child. Ann Dermatol Venereol 1997; 124: 857–60.
- 39Weiss SW, Enzinger FM. Spindle cell hemangioendothelioma. A low-grade angiosarcoma resembling a cavernous hemangioma and Kaposi's sarcoma. Am J Surg Pathol 1986; 10: 521–30.
- 40Perkins P, Weiss SW. Spindle cell hemangioendothelioma. An analysis of 78 cases with reassessment of its pathogenesis and biologic behavior. Am J Surg Pathol 1996; 20: 1196–204.
- 41Ding J, Hashimoto H, Imayama S et al. Spindle cell haemangioendothelioma: probably a benign vascular lesion not a low-grade angiosarcoma. A clinicopathological, ultrastructural and immunohistochemical study. Virchows Arch A Pathol Anat Histopathol 1992; 420: 77–85.
- 42Fletcher CD, Beham A, Schmid C. Spindle cell haemangioendothelioma: a clinicopathological and immunohistochemical study indicative of a non-neoplastic lesion. Histopathology 1991; 18: 291–301.
- 43Imayama S, Murakamai Y, Hashimoto H, Hori Y. Spindle cell hemangioendothelioma exhibits the ultrastructural features of reactive vascular proliferation rather than of angiosarcoma. Am J Clin Pathol 1992; 97: 279–87.
- 44Fukunaga M, Ushigome S, Nikaido T et al. Spindle cell hemangioendothelioma: an immunohistochemical and flow cytometric study of six cases. Pathol Int 1995; 45: 589–95.